On November 7, 2025, VolitionRx Ltd amended its Underwriting Agreement to allow the Underwriter to exercise the Over-Allotment Option separately for shares and warrants, resulting in the purchase of 1,194,000 additional shares and 1,732,500 warrants at $0.52 each. This is part of their public offering of 11,550,000 shares, initially priced at $0.52.